Advertisement

Topics

Companies Related to "The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma" [Most Relevant Company Matches] RSS

08:59 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma" found in our extensive corporate database of over 50,000 company records.

Showing "Genetic Characteristics South Korean Patients With Primary Congenital" Companies 1–25 of 5,200+

Relevant

Korea4Health

Korea4Health is the gateway to the internationally renowned Korean healthcare services prepared for the US patients exploring the most advanced and affordable healthcare solutions. Initiated by the public-private partnership, it is operated by KHIDI USA, Korean Government agency under the Ministry of Health and Welfare featuring the best medical procedu...


CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical...

CMP Media Korea Co. Ltd.

CMP Media Korea organises XpoChem and XpoPharm, as well as the XpoChem and XpoPharm conferences, and as a Korean network of CMP organising world-renowned pharmaceutical and chemical events, CPhI Worldwide, CPhI Japan, CPhI China, CPhI India, CPhI South America, and Informex USA etc. provides opportunities for international companies to access the Korean market and assists with the development ...


Children’s HeartLink

Founded in 1969, Children’s HeartLink is a nonprofit organization partnering with health care centers in underserved regions of the world to promote sustainable cardiac care for children with congenital or acquired heart disease. Congenital heart disease is the world's most common major birth defect, affecting one in every 120 children. Nearly ninety ...

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis ...

Artificial Development, Inc.

Artificial Development is building CCortex™, an simulation of the Human Cortex and peripheral systems, running on a computer cluster. CCortex will enable the development an array of systems and products that can replicate, partially or completely, some of the primary characteristics of Human Intelligence. Those characteristics include pattern recognition, verbal and visual communication, knowled...

Partners in Primary Care

Partners in Primary Care (Partners) is a primary care medical group practice and is part of a larger group of over 60 primary care offices in Florida, South Carolina and Texas operating under the names CAC Florida Medical Centers, Continucare Medical Centers, MetCare and Partners in Primary Care. Partners has a strong emphasis on senior-focused primary car...

Melior Pharmaceuticals Inc.

Bukwang Pharm. Co., Ltd. is a leading Korean pharmaceutical company listed on the Korean Stock Exchange [KRX:003000]. The company has been in business for over 50 years, and achieved US$130 million in sales in 2012. Sales are primarily derived from products licensed from Europe, the United States and Japan. The company is currently investing significant re...

Melior Pharmaceuticals I, Inc.

Bukwang Pharm. Co., Ltd. is a leading Korean pharmaceutical company listed on the Korean Stock Exchange [KRX:003000]. The company has been in business for over 50 years, and achieved US$130 million in sales in 2012. Sales are primarily derived from products licensed from Europe, the United States and Japan. The company is currently investing significant re...

Pharma Koreana Ltd.

Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorro...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes support for physicians, as well as genetic counseling as part of every order. Color’s goal is to expand physician-supported access to genetic information for breast and ovarian ...

Genetic Technologies Limited

Genetic Technologies was an early pioneer in recognizing important new applications for “non-coding” DNA (Deoxyribonucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all spec...

R-Health

R-Health's innovative Direct Primary Care model is designed to deliver better healthcare at a lower cost. R-Health Direct Primary Care liberates primary care from the administrative cost burden and negative incentives of the current fee-for-service insurance system. Physicians can deliver personalized, effective, coordinated, patient-centered care that is ...

Korean Urological Association

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for reproductive indications from tiny quantities of DNA – as small as that from a single cell. Natera operates a CLIA laboratory in Redwood City, Calif., providing a host of pr...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

Korean Institute of Science and Technology (KIST)

NEOFECT

Korean-American health tech startup NEOFECT was founded in 2010 to create an environment where stroke survivors, doctors, and therapists can objectively evaluate the results of patient rehabilitation. Fun, game-based rehabilitation exercises motivate patients while simultaneously providing actionable, quantifiable data to medical professionals.

Children's Healthcare of Atlanta

Congenital heart defects are the most common birth defect, affecting one in 100 newborns each year. Treating nearly 30,000 children every year, the Children's Healthcare of Atlanta Sibley Heart Center has garnered widespread national recognition for our innovative treatments, leading-edge research and compassionate care. And, in 2005, the Children's Sibley Heart Center was named one of the country...

Neurotech Pharmaceutical Inc

Neurotech Pharmaceutical Inc. is a core biotechnology company in South Korea , established in 1998.Neurotech seeks to discover, develop, and commercialize major pharmaceutical products to cure brain related diseases, such as stroke, Parkinson ' s disease, Alzheimer ' s disease, spinal cord injury, and glaucoma. Our business strategy is to understand mechanisms of degenerative and regenerative neur...

RecordAF registry

The RecordAF survey recruited 5,604 patients with recent onset atrial fibrillation from 21 countries spanning North and South America, Europe and Asia (5,171 patients - 92.3 percent were evaluable after 12-month follow-up). They were followed-up for a period of one year. The primary outcomes of the study were therapeutic success and clinical outcomes associated with rhythm- and rate-control st...

Cigna Corporation and Primary Partners LLC

Primary Partners LLC was one of the first Accountable Care Organizations (ACOs) in the country. The organization is physician owned, led and managed with over 60 providers in four counties in Central Florida. Its vision is to exemplify quality care models, while allowing physicians to maintain independent practices and to provide a voice for patients and i...

Pulmonary Hypertension Association

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual. The function of the heart and lungs is severely compromised, manifested by a limited exercise capacity, and, ultimately, a reduced life expectancy. Approximately 100,000 people in Europe and the United S...

Dallas Thrombosis Hemostasis & Difficult Hematology Clinical Center

Thrombosis is clearly the most common cause of death in the United States. About two million individuals in the U.S.A. die each year from an arterial or venous thrombosis or the consequences. By comparison, about 540,000 individuals in the USA die each year from cancer. About 80% to 90% of all causes of thrombosis can now be defined with respect to cause. Of these, up to 90% of all patients ha...

Australian Grain Technologies

AGT's partners and shareholders have a long and respected tradition at the cutting edge of grain breeding research and industry development. They include:• South Australian Research Development Institute • University of Adelaide • Grains Research and Development CorporationAGT is committed to releasing only well-adapted varieties offering superior combinations of agronomic, yield and grain q...


More From BioPortfolio on "The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks